Mindimmune Therapeutics
Organisation
People
Chief science officer
Sources: reporter.nih.gov
Grants and prizes
Targeting CD11c immune cells to alleviate cerebral amyloid angiopathy and amyloid-related imaging abnormality in patients with Alzheimer's disease, R43AG102103, US$496.4k, 17 Sept 2026
Sources: reporter.nih.gov
Named in competing interests
Plasma proteomic Alzheimer's risk score: Biological age clock and pseudotime trajectory
Consulting or advice, Board or leadership role, 1 Oct 2025
Sources: pubmed.ncbi.nlm.nih.gov